Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of ...

Hundreds gathered to support muscular dystrophy research as the Muscular Dystrophy Association marked its 75th anniversary.

Sarepta Therapeutics (NasdaqGS:SRPT) saw its share price rise by 19% over the past month, a move that notably outpaced the broader market's 1% increase for the week and the 13% gain over the year.

Doctors say while prostate cancer is common, 80-85% of cases are considered slow growing and need to be monitored but will ...